Glyn Owain Edwards
Directeur/Membre du Conseil chez Summit Therapeutics Ltd.
Provenance du réseau au premier degré de Glyn Owain Edwards
Entité | Type d'entité | Industrie | |
---|---|---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.
33
| Subsidiary | Pharmaceuticals: Major | 33 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom.
13
| Extinct | Financial Conglomerates | 13 |
OxSonics Ltd.
OxSonics Ltd. Hospital/Nursing ManagementHealth Services OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.
7
| Holding Company | Hospital/Nursing Management | 7 |
OrthoSon Ltd.
OrthoSon Ltd. Medical SpecialtiesHealth Technology OrthoSon Ltd. engages in the development of novel medical device for the treatment of chronic low back pain. The company was founded by Constantin Coussios and is headquartered in Oxford, the United Kingdom.
4
| Holding Company | Medical Specialties | 4 |
Antisoma Research Ltd.
2
| Subsidiary | 2 | |
The National Cancer Research Institute
The National Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services The National Cancer Research Institute (NCRI) is an organization that focuses on advancing cancer research with the input of cancer patients and carers. The non-profit company is based in London, UK. The British company collects research funding data to understand how money is distributed across various areas of research and identify any gaps. NCRI is creating a research-ready workforce, strengthening the retention of early career researchers and facilitating the early interaction of clinical and preclinical researchers. The company aims to deliver better outcomes for those affected by cancer by identifying gaps in research and addressing them.
1
| Non-Profit Organization | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Glyn Owain Edwards via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Comptroller/Controller/Auditor | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director of Finance/CFO Chief Operating Officer Director/Board Member General Counsel General Counsel | |
VERNALIS | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
SUMMIT THERAPEUTICS INC. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member General Counsel General Counsel Chief Tech/Sci/R&D Officer Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member | |
University of Oxford | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
PULSE BIOSCIENCES, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member | |
University of Cambridge | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London. | Investment Managers | Founder Private Equity Investor Consultant / Advisor | |
OrganOx Ltd.
OrganOx Ltd. Electronic Equipment/InstrumentsElectronic Technology OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Founder Chief Operating Officer | |
Robert W. Duggan & Associates
Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Investment Managers | Founder Corporate Officer/Principal Corporate Officer/Principal | |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Medical/Nursing ServicesHealth Services The Francis Crick Institute Ltd. operates as a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. The firms works helps to understand why disease develops and to find new ways to treat, diagnose, and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
MuOx Ltd.
MuOx Ltd. BiotechnologyHealth Technology Part of Summit Therapeutics, Inc., MuOx Ltd. is a British company that develops utrophin modulators and biological screening equipment. The company is based in Abingdon, UK. The company was founded in 2012 by Stephen Davies John Davies. MuOx was acquired by Summit Therapeutics Ltd. on November 25, 2013 for $5.27 million. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Operating Officer | |
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Glaxo Group Research Ltd. | Chief Tech/Sci/R&D Officer General Counsel | ||
OKYO PHARMA LIMITED | Biotechnology | Chairman Director/Board Member | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree | |
REDX PHARMA PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Oxford Photovoltaics Ltd.
Oxford Photovoltaics Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services 454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
SCANCELL HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Oxford Biotrans Ltd.
Oxford Biotrans Ltd. Chemicals: Major DiversifiedProcess Industries Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Maky Zanganeh & Associates, Inc. | Founder General Counsel | ||
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director of Finance/CFO Chief Executive Officer | |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder Chief Operating Officer | |
KEWILL LTD | Packaged Software | Chairman | |
TIALIS ESSENTIAL IT PLC | Data Processing Services | Chairman |
Statistiques
Internationale
Royaume-Uni | 29 |
Etats-Unis | 15 |
Allemagne | 2 |
Finlande | 2 |
Suisse | 2 |
Sectorielle
Health Technology | 24 |
Commercial Services | 5 |
Consumer Services | 5 |
Finance | 5 |
Technology Services | 4 |
Opérationnelle
Director/Board Member | 362 |
Corporate Officer/Principal | 111 |
Chairman | 92 |
Independent Dir/Board Member | 66 |
Founder | 48 |
Relations les plus connectées
Insiders | |
---|---|
Grahame Cook | 53 |
Jim Mellon | 51 |
Andrew Richards | 44 |
Frank Armstrong | 41 |
George Elliott | 35 |
David Wurzer | 31 |
Birgit Stattin Norinder | 29 |
Leopoldo Giampaolo Zambeletti | 22 |
Michael Lewis | 21 |
Matthew Frohn | 20 |
Robert Duggan | 18 |
Stephen Davies | 18 |
Dale J. Boden | 18 |
Ursula Ney | 16 |
James Mallinson | 15 |
- Bourse
- Insiders
- Glyn Owain Edwards
- Connexions Sociétés